Post by Organon

For too long the impact of menstrual pain has been underestimated. Dysmenorrhea is one of the most common and undertreated women’s health conditions, affecting millions globally and significantly impacting daily activities, education, work, and overall well-being. Today, Organon received regulatory approval in Japan for one of its products for dysmenorrhea. This milestone highlights Organon’s commitment to addressing this long‑standing unmet need and brings greater recognition to this condition, expanding awareness and access for women seeking support. We are proud of the collaboration and dedication of our colleagues in Organon Japan and across the organization who helped make this achievement possible. #Dysmenorrhea #WomensHealth #HereForHerHealth